Work

Abstract PS1-11-16: Clinical and Molecular Landscape of ESR1 and PIK3CA Co-Mutated Hormone Receptor-Positive Metastatic Breast Cancer (HR+ MBC): Insights from 8,626 Patients Including Polyclonality and TP53 Alterations

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-11-16

Authors: A. Sivapiragasam, A. Dugan, S. Fragkogianni, M. Ciampricotti, E. Williams

Institutions: Medical University of South Carolina, Tempus Labs (United States)

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129326449

Cites:

Cited by:

Related to: